However, 2h mAb-mediated protection was only statistically significant for plasma eNAMPT and Ang-2 levels indicating that delayed ALT-100 mAb delivery, even up to 6 h after the onset of ARDS/VILI, significantly reduces inflammatory cascade activation. This evidence concerns the gene GPT and acute respiratory distress syndrome.